Related Experiment Video
Updated: May 2, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
p53 N‑terminal binding and stabilisation by PIAS3 inhibits MDM2‑induced p53 ubiquitination and regulates cell growth
Ziyi Zhao1, Lan Wu1, Huimin Shi1
1Key Laboratory of Bioresources and Ecoenvironment, Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, P.R. China.
Abstract:
Mouse double minute 2 homolog (MDM2) binds to p53 through the 1-52 amino acid region of p53, in order to ubiquitinate p53. MDM2 thus destabilises p53 and inhibits the effect of p53 on cell cycle arrest and apoptosis. In the present study, the 1-52 amino acid region of the wild-type (wt) p53 protein was stably expressed in H1299 cells. The lysate of the transfected cells was then analysed using co-immunoprecipitation. A specific fraction of the precipitate was subjected to mass spectrometry analysis, which revealed that p53 bound to protein inhibitor of activated STAT3 (PIAS3). To the best of our knowledge, the present study is the first to report that the interaction of PIAS3 with p53 occurs through the 1-52 amino acid region of p53. Overexpression of PIAS3 in the A549 wt p53-expressing cell line was found to significantly increase the half‑life of p53 in the presence of cycloheximide, an inhibitor of protein synthesis. However, PIAS3 overexpression did not affect p53 mRNA levels. Furthermore, PIAS3 overexpression was observed to decrease p53 ubiquitination. Protein-protein interaction analysis revealed that PIAS3 binds to the 1-52 amino acid region of p53, thus disrupts the formation of the p53‑MDM2 complex. In addition, overexpression of PIAS3 in A549 cells was found to enhance the transcription of the p53‑transactivated target p21/waf1, due to p53 accumulation, which led to an increase in p53 binding to the p21 gene promoter. These findings indicate that this newly identified p53‑PIAS3 interaction through the 1-52 amino acid region of p53, reduces p53‑MDM2 complex formation, which not only increases the half-life of p53, but also its transactivation of target genes.
Insights
The protein inhibitor of activated STAT3 (PIAS3) binds to the p53 protein, stabilizing it and enhancing its tumor-suppressing functions. This interaction prevents MDM2 binding, increasing p53 levels and activity.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Mouse double minute 2 homolog (MDM2) targets p53 for degradation, inhibiting its tumor-suppressive functions.
- Understanding p53 regulation is crucial for cancer therapy.
Purpose of the Study:
- To investigate novel interactions with p53.
- To identify proteins that bind to the N-terminal region of p53 (amino acids 1-52).
Main Methods:
- Stable expression of wild-type p53's N-terminal region in H1299 cells.
- Co-immunoprecipitation and mass spectrometry to identify binding partners.
- Overexpression of PIAS3 in A549 cells to assess p53 stability and activity.
Main Results:
- Protein inhibitor of activated STAT3 (PIAS3) was identified as a binding partner of p53.
- PIAS3 binds to the p53 N-terminal region (amino acids 1-52), disrupting the p53-MDM2 complex.
- PIAS3 overexpression increased p53 half-life, reduced p53 ubiquitination, and enhanced p53-mediated transcription of p21/waf1.
Conclusions:
- PIAS3 is a novel interactor of p53, binding to its N-terminal region.
- The p53-PIAS3 interaction stabilizes p53 by inhibiting MDM2-mediated degradation.
- This interaction enhances p53's tumor-suppressive transcriptional activity.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity

